Purchase by Kevin Tang of 62144 shares of Odonate Therapeutics

ODTCDelisted Stock  USD 1.80  0.00  0.00%   
About 56% of Odonate Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Odonate Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Odonate Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Odonate Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Odonate Therapeutics Inc director. General open market or private purchase of non-derivative or derivative security

Read at macroaxis.com
Odonate insider trading alert for perchase of common stock by Kevin Tang, Chief Executive Officer, on 3rd of February 2023. This event was filed by Odonate Therapeutics Inc with SEC on 2020-12-23. Statement of changes in beneficial ownership - SEC Form 4

Odonate Therapeutics Fundamental Analysis

We analyze Odonate Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Odonate Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Odonate Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Odonate Therapeutics is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Peers

Trending Equities

BBY  2.08   
0%
100.0%
TGT  1.71   
0%
82.0%
INTC  1.69   
0%
81.0%
AA  1.20   
0%
57.0%
AAPL  1.02   
0%
49.0%
C  1.01   
0%
48.0%
HD  0.45   
0%
21.0%
IBM  0.22   
0%
10.0%
UPS  0.03   
0%
1.0%
MET  0.02   
1.0%
0%
CVX  0.11   
5.0%
0%
CVS  0.18   
8.0%
0%
S  0.46   
22.0%
0%
T  0.47   
22.0%
0%
AAL  0.82   
39.0%
0%
WFC  1.35   
64.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Odonate Pink Sheet

If you are still planning to invest in Odonate Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Odonate Therapeutics' history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas